A modified tail suspension test for the assessment of behavioral despair in mice after stroke.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Acta Pharmacologica Sinica

• Publication date

  2026-02-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41401-025-01735-zPMID 41730997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Astrocytic ALKBH5 in stress response contributes to depressive-like behaviors in mice

  2024cited by this paper
• Rodent tests of depression and anxiety: Construct validity and translational relevance

  2024cited by this paper
• Molecular mechanisms underlying major depressive disorder and post-stroke affective disorders.

  2023cited by this paper
• Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window

  2023cited by this paper
• Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects

  2023cited by this paper
• A thalamic-primary auditory cortex circuit mediates resilience to stress.

  2023cited by this paper
• Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb

  2023cited by this paper
• Test, Rinse, Repeat: A Review of Carryover Effects in Rodent Behavioral Assays.

  2022cited by this paper
• Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN

  2022cited by this paper
• The advances of post-stroke depression: 2021 update

  2021cited by this paper
• Neuronal Nitric Oxide Synthase in Nucleus Accumbens Specifically Mediates Susceptibility to Social Defeat Stress through Cyclin-Dependent Kinase 5

  2021cited by this paper
• Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

  2021cited by this paper
• Hemispheric stroke: Mood disorders.

  2021cited by this paper
• A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABAARs

  2021cited by this paper
• Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.

  2020cited by this paper
• Cell-type specific modulation of NMDA receptors triggers antidepressant actions

  2020cited by this paper
• Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses

  2020cited by this paper
• Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.

  2020cited by this paper
• US Food and Drug Administration approval of esketamine and brexanolone.

  2019cited by this paper
• Psychomotor Retardation in Depression: A Critical Measure of the Forced Swim Test.

  2019cited by this paper
• The future of rodent models in depression research

  2019cited by this paper
• AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.

  2018cited by this paper
• DeepLabCut: markerless pose estimation of user-defined body parts with deep learning

  2018cited by this paper
• Sucrose preference test for measurement of stress-induced anhedonia in mice

  2018cited by this paper
• Depression

  2018cited by this paper
• Chronic Fluoxetine Induces Activity Changes in Recovery From Poststroke Anxiety, Depression, and Cognitive Impairment

  2017cited by this paper
• Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study.

  2017cited by this paper
• Dynamically Timed Stimulation of Corticolimbic Circuitry Activates a Stress-Compensatory Pathway.

  2017cited by this paper
• Persistent post-stroke depression in mice following unilateral medial prefrontal cortical stroke

  2016cited by this paper
• The chronic mild stress (CMS) model of depression: History, evaluation and usage

  2016cited by this paper
• Astrocytic TNFα regulates the behavioral response to antidepressants.

  2015cited by this paper
• Neuropsychiatric outcomes of stroke.

  2014cited by this paper
• Of mice and men: modelling post‐stroke depression experimentally

  2014cited by this paper
• Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression.

  2012cited by this paper
• Hippocampal nitric oxide contributes to sex difference in affective behaviors

  2012cited by this paper
• The tail suspension test.

  2011cited by this paper
• Hippocampal Telomerase Is Involved in the Modulation of Depressive Behaviors

  2011cited by this paper
• Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95

  2010cited by this paper
• Rodent models in depression research: Classical strategies and new directions

  2010cited by this paper
• Animal models of neuropsychiatric disorders

  2010cited by this paper
• The molecular neurobiology of depression

  2008cited by this paper
• Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice

  2007cited by this paper
• The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.

  2005cited by this paper
• The tail suspension test: A new method for screening antidepressants in mice

  2004cited by this paper
• Preclinical models: status of basic research in depression.

  2002cited by this paper
• Limitations on the use of the C57BL/6 mouse in the tail suspension test

  2001cited by this paper
• Depression: a new animal model sensitive to antidepressant treatments

  1977cited by this paper
• Behavioral despair in mice: a primary screening test for antidepressants.

  1977cited by this paper
• JoVE Video Dataset

  year unknowncited by this paper

• No citing papers are available for this paper.